Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Renal Cell × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 5 Glioblastoma 4 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphedema 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Early-stage Peripheral Non-small Cell Lung Cancer 1 Disease 1 Depression 1 Carcinoma, Renal Cell 1

Interventions

Nivolumab 129 pembrolizumab 114 Sunitinib 107 Everolimus 63 Bevacizumab 63 Sorafenib 62 cabozantinib 59 pazopanib 55 Ipilimumab 54 Axitinib 49 aldesleukin 47 Magnetic Resonance Spectroscopy 39 Cyclophosphamide 36 Interleukin-2 33 Radiosurgery 32 Interferon-alpha 32 lenvatinib 30 Specimen Handling 26 temsirolimus 23 atezolizumab 23 belzutifan 21 fludarabine phosphate 20 Gemcitabine 20 Radiotherapy 17 Interferon alpha-2 16 Biopsy 16 fludarabine 15 durvalumab 15 avelumab 15 Paclitaxel 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01967407 2014-11-19

IRENE

University of Magdeburg

Phase 1/2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡